physalaemin [6342]



physalaemin


SMILES CSCCC(NC(=O)C(CC(C)C)NC(=O)CNC(=O)C(Cc1ccc(O)cc1)NC(=O)C(Cc1ccccc1)NC(=O)C(CCCCN)NC(=O)C(CC(N)=O)NC(=O)C1CCCN1C(=O)C(CC(=O)O)NC(=O)C(C)NC(=O)C1CCC(=O)N1)C(N)=O
InChIKey SHSUJLMLURFKID-UHFFFAOYSA-N
Sequence XADPNKFYGLM
HELM PEPTIDE1{[*C(=O)C1CCC(=O)N1 |$_R2;;;;;;;;$|].(A,[dA]).(D,[dD]).(P,[dP]).(N,[dN]).(K,[dK]).(F,[dF]).(Y,[dY]).G.(L,[dL]).(M,[dM]).[am]}$$$$V2.0

Chemical Properties

Hydrogen bond acceptors 17
Hydrogen bond donors 15
Rotatable bonds 37
Log P -3.775
Molecular weight (Da) 1264.6
Stereochemistry info unspecified

Database connections

Model (AF2) NK1
GPCRdb related ligands

Bioactivities

Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database
Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database

physalaemin


Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections

Model (AF2) NK1

Compound is not listed as a drug.